Lilly’s stock was tumbling as disappointing trial data for an oral weight-loss pill offset an upbeat earnings report and outlook.
InsuranceMarketWork & Careers
Lilly’s stock was tumbling as disappointing trial data for an oral weight-loss pill offset an upbeat earnings report and outlook.
This article was automatically published by finance.codetrip.uk.
This article was automatically published by finance.codetrip.uk.
“I have two young children, and I have a great mortgage rate.”